Delivery Order SPE2DB25D3201-SPE2DB25FNUEE
- Not listed
- The Defense Logistics Agency awarded a $9,127.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vitamin K-1 10 mg/ml ampules, with an ultimate completion date of June 18, 2025. The award, issued on June 17, 2025, is unset-aside and competitively awarded, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,178.24 to AmerisourceBergen Drug Corp for Vitamin K-1 1 mg/0.5 ml ampuls on April 21, 2025, with completion scheduled for April 22, 2025. This firm fixed-price delivery order was not designated as a set-aside and represents a competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,175.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vitamin K-1 10 mg/ml ampules, with performance in Conshohocken, Pennsylvania and an ultimate completion date of August 21, 2025. This non-set-aside competitive award represents a routine pharmaceutical supply transaction under the company's broader federal contract portfolio. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Vitamin K-1 10 mg/mL Ampul/mL, a critical medical commodity, with a ceiling value of $3,405.50 and a period of performance through March 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vitamin K-1 1 mg/0.5 ml ampules, with a ceiling value of $1,162.80 and a period of performance through May 12, 2025. The contract is not set aside and was awarded on a firm fixed-price basis. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a $1,452.64 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Phytonadione 10 mg/ml ampules. This is a firm fixed price contract with no set-aside designation, classified as a child contract under a larger vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. Phytonadione, commonly known as Vitamin K1, is a critical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of Vitamin K-1 10 mg/ml ampulml, a pharmaceutical product. The contract has a ceiling value of $4,060.14 and an ultimate completion date of January 30, 2024. The award does not have a set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical...
- This federal contract award, valued at $13,246.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vitamin K-1 10 mg/ml ampules. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive...
- The Defense Logistics Agency awarded a $2,132.69 delivery order to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes on June 13, 2025, with an ultimate completion date of June 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Phytonadione, commonly known as Vitamin K1, is a critical pharmaceutical used to treat vitamin K...
- The Defense Logistics Agency awarded a $55,089.27 delivery order to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes on July 3, 2025, with an ultimate completion date of July 7, 2025. This is a firm fixed price, non-set-aside contract utilizing a competitively awarded delivery order model. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Phytonadione, commonly known as Vitamin K1, is a critical pharmaceutical product used...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNUEEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vitamin K-1 10 mg/ml ampules, valued at $3,568.08 under a firm fixed-price contract type. The award was made on June 25, 2025, with an ultimate completion date of June 26, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete openly in federal pharmaceutical procurement. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its role as a primary pharmaceutical supplier across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard through flexible contract vehicles designed to meet global military healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 6/25/25 |